Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab and Cyclophosphamide in Pediatric Solid Tumors
NCT02901145Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Nov 2016
- Primary completion
- Nov 2019
- Modality
- Monoclonal Antibodies
01
Overview
Phase 2, open-label trial of nivolumab in solid tumor, sponsored by Hadassah Medical Organization. Status: unknown.
02
Drugs
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02901145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02901145.